Table 3 Mortality among COVID-19 hypertensive patients (with or without other comorbidities, < or > 2 week of admission)
Variable | Died(n(%)) | Survived (Recovered) (n(%)) | Total(n(%)) | Χ2 | P |
|---|---|---|---|---|---|
Number of comorbidities |  |  |  | 19.09 | < 0.001 |
 1 (Hypertension only) | 16 (8.1) | 181 (91.9) | 197 (100.0) |  |  |
  > 2 | 25 (27.5) | 66 (72.5) | 91 (100.0) |  |  |
Total | 41 (14.2) | 247 (85.8) | 288 (100.0) | Â | Â |
Time till endpoint |  |  |  |  | < 0.001* |
 < 14 days | 39 (21.0) | 147 (79.0) | 186 (100.0) |  |  |
 ≥ 14–28 | 2 (2.0) | 100 (98.0) | 101 (100.0) |  |  |
Total | 41 (14.2) | 247 (85.8) | 288 (100.0) | Â | Â |
Endpoint within 2 weeks (n = 186) | |||||
 Hypertension only | 16 (16.2) | 83 (83.8) | 99 (100.0) | 2.95 | 0.086 |
 Hypertension with other comorbidities | 23 (26.4) | 64 (73.6) | 87 (100.0) |  |  |
Total | 39 (21.0) | 147 (79.0) | 186 (100.0) | Â | Â |